Psychotherapy for inflammatory bowel disease: A review and update

Journal of Crohn's and Colitis

Volumn 7, Issue 12, 2013, Pages 935-949

  McCombie, Andrew M ^a   Mulder, Roger T ^a   Gearry, Richard B ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cognitive behaviour therapy; Crohn's disease; Psychotherapy; Ulcerative colitis

Indexed keywords

ABDOMINAL PAIN; ANXIETY DISORDER; COGNITIVE THERAPY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DISEASE COURSE; ENTERITIS; FATIGUE; FOLLOW UP; GROUP THERAPY; HOSPITALIZATION; HUMAN; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBLEM SOLVING; PSYCHOLOGIST; PSYCHOTHERAPIST; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; REVIEW; SAMPLE SIZE; SCREENING; STANDARDIZATION; STRESS MANAGEMENT; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT DURATION;

CBT; CCBT; COGNITIVE BEHAVIOUR THERAPY; COGNITIVE BEHAVIOURAL THERAPY; COMPUTERISED COGNITIVE BEHAVIOURAL THERAPY; CROHN'S DISEASE; IBS; IRRITABLE BOWEL SYNDROME; PSYCHOTHERAPY; QOL; QUALITY OF LIFE; RA; RHEUMATOID ARTHRITIS; TAU; TREATMENT AS USUAL; ULCERATIVE COLITIS; WAITLIST CONTROL; WLC;

ANXIETY; DEPRESSION; FATIGUE; HOSPITALIZATION; HUMANS; INFLAMMATORY BOWEL DISEASES; MEDICATION ADHERENCE; PAIN MANAGEMENT; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE;

EID: 84887608926     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.02.004     Document Type: Review

References (120)

1. Nicholls J., Tekkis P. Ulcerative colitis. A companion to specialist surgical practice: colorectal surgery 2005, 129-162. Elsevier Saunders, Philadelphia, PA. 3rd ed. K. Phillips (Ed.).
2. Crohn's and Colitis Foundation of New Zealand. Crohn's and Colitis Foundation of New Zealand Wellington; Available from: http://www.crohnsandcolitis.org.nz/about_crohns_and_colitis.
3. Bernstein C.N., Blanchard J.F., Rawsthorne P., Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol Apr 2001, 96(4):1116-1122. [Research Support, Non-U.S. Gov't].
4. Langholz E. Current trends in inflammatory bowel disease: the natural history. Ther Adv Gastroenterol Mar 2010, 3(2):77-86.
5. Larsen S., Bendtzen K., Nielsen O.H. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Ann Med Mar 2010, 42(2):97-114. [Review].
6. Bouma G., Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003, 3:521-533.
7. Stein J., Hartmann F., Dignass A.U. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol Nov 2010, 7(11):599-610.
8. Wilson J., Hair C., Knight R., Catto-Smith A., Bell S., Kamm M., et al. High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian incidence study. Inflamm Bowel Dis Sep 2010, 16(9):1550-1556. [Research Support, Non-U.S. Gov't].
9. Gearry R.B., Richardson A., Frampton C.M.A., Collett J.A., Burt M.J., Chapman B.A., et al. High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study. Inflamm Bowel Dis Oct 2006, 12(10):936-943. [Research Support, Non-U.S. Gov't].
10. Binder V. Epidemiology of IBD during the twentieth century: an integrated view. Best Pract Res Clin Gastroenterol Jun 2004, 18(3):463-479.
11. Ouyang Q., Tandon R., Goh K.-L., Ooi C.J., Ogata H., Fiocchi C. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol Jul 2005, 21(4):408-413. [Review].
12. Thia K.T., Loftus E.V., Sandborn W.J., Yang S.-K. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol Dec 2008, 103(12):3167-3182. [Review].
13. Souza M.H.L.P., Troncon L.E.d.A., Rodrigues C.M., Viana C.F.G., Onofre P.H.C., Monteiro R.A., et al. Trends in the occurrence (1980-1999) and clinical features of Crohn's disease and ulcerative colitis in a university hospital in southeastern Brazil. Arq Gastroenterol Apr-Jun 2002, 39(2):98-105. [English Abstract].
14. Appleyard C.B., Hernandez G., Rios-Bedoya C.F. Basic epidemiology of inflammatory bowel disease in Puerto Rico. Inflamm Bowel Dis Mar 2004, 10(2):106-111. [Research Support, U.S. Gov't, P.H.S.].
15. Bonen D.K., Cho J.H. The genetics of inflammatory bowel disease. Gastroenterology Feb 2003, 124(2):521-536. [Review].
16. Gearry R.B., Richardson A.K., Frampton C.M., Dodgshun A.J., Barclay M.L. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol Feb 2010, 25(2):325-333. [Research Support, Non-U.S. Gov't].
17. Bernstein C.N., Rawsthorne P., Cheang M., Blanchard J.F. A population-based case control study of potential risk factors for IBD. Am J Gastroenterol May 2006, 101(5):993-1002. [Research Support, Non-U.S. Gov't].
18. Sparrow M., Lim W., Hanauer S. Mesalazine for maintenance therapy in ulcerative colitis-how much, how long?. Challenges in inflammatory bowel disease 2006, Blackwell Publishing Ltd., Oxford. 2nd ed. D. Jewell, N. Mortensen, A. Steinhart, J. Pemberton, B. Warren (Eds.).
19. Botoman V.A., Bonner G.F., Botoman D.A. Management of inflammatory bowel disease. Am Fam Physician Jan 1 1998, 57(1):57-68. [Review].
20. Thompson-Fawcett M., Mortensen N. Crohn's disease 2005, Elsevier Saunders, Philadelphia, PA. 3rd ed. K. Phillips (Ed.).
21. Gearry R.B., Irving P.M., Barrett J.S., Nathan D.M., Shepherd S.J., Gibson P.R. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. J Crohns Colitis Feb 2009, 3(1):8-14.
22. Barrett J.S., Gibson P.R. Clinical ramifications of malabsorption of fructose and other short-chain carbohydrates. Pract Gastroenterol 2007, 31(8):51-65.
23. Addolorato G., Capristo E., Stefanini G.F., Gasbarrini G. Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol Oct 1997, 32(10):1013-1021.
24. Andrews H., Barczak P., Allan R.N. Psychiatric illness in patients with inflammatory bowel disease. Gut Dec 1987, 28(12):1600-1604.
25. Angelopoulos N.V., Mantas C., Dalekos G., Vasalos K., Tsianos E. Psychiatric factors in patients with ulcerative colitis according to disease activity. The European Journal of Psychiatry 1996, 10(2):87-99.
26. Graff L.A., Walker J.R., Bernstein C.N. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis Jul 2009, 15(7):1105-1118. [Review].
27. Mikocka-Walus A.A., Turnbull D.A., Moulding N.T., Wilson I.G., Andrews J.M., Holtmann G.J. Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review. Inflamm Bowel Dis Feb 2007, 13(2):225-234. [Review].
28. Bennebroek Evertsz F., Thijssens N.A.M., Stokkers P.C.F., Grootenhuis M.A., Bockting C.L.H., Nieuwkerk P.T., et al. Do inflammatory bowel disease patients with anxiety and depressive symptoms receive the care they need?. J Crohns Colitis 2012, 6(1):68-76. [Date of Publication: February 2012.; 2012].
29. Moreno-Jimenez B., Lopez Blanco B., Rodriguez-Munoz A., Garrosa Hernandez E. The influence of personality factors on health-related quality of life of patients with inflammatory bowel disease. J Psychosom Res Jan 2007, 62(1):39-46.
30. Cámara R.J.A., Gander M.-L., Begré S., von Känel R., Group, S.I.B.D.C.S. Post-traumatic stress in Crohn's disease and its association with disease activity. Frontline Gastroenterol January 1 2011, 2(1):2-9. [2011].
31. Cámara R.J.A., Ziegler R., Begré S., Schoepfer A.M., von Känel R. The role of psychological stress in inflammatory bowel disease: quality assessment of methods of 18 prospective studies and suggestions for future research. Digestion 2009, 80(2):129-139.
32. Curtis CE. Disease activity, coping behavior, social support, and illness-related self-disclosure among persons with inflammatory bowel disease: a framework for quality of life. Dissertation Abstracts International: Section B: The Sciences and Engineering [Dissertation] 2009;70(3-B):1939.
33. Drossman D.A., Leserman J., Li Z., Keefe F., Hu Y.J., Toomey T.C. Effects of coping on health outcome among women with gastrointestinal disorders. Psychosom Med 2000, 62(3):309-317. [Research Support, U.S. Gov't, P.H.S.].
34. Graff L.A., Walker J.R., Clara I., Lix L., Miller N., Rogala L., et al. Stress coping, distress, and health perceptions in inflammatory bowel disease and community controls. Am J Gastroenterol Dec 2009, 104(12):2959-2969. [Comparative Study].
35. Kiebles J.L., Doerfler B., Keefer L. Preliminary evidence supporting a framework of psychological adjustment to inflammatory bowel disease. Inflamm Bowel Dis Oct 2010, 16(10):1685-1695. [Research Support, N.I.H., Extramural].
36. Pellissier S., Dantzer C., Canini F., Mathieu N., Bonaz B. Psychological adjustment and autonomic disturbances in inflammatory bowel diseases and irritable bowel syndrome. Psychoneuroendocrinology June 2010, 35(5):653-662.
37. Purc-Stephenson RJ. A gift wrapped in barbed wire: personal growth among individuals with arthritis or inflammatory bowel disease. Dissertation Abstracts International: Section B: The Sciences and, Engineering [Dissertation] 2009;70(3-B):1985.
38. Raffle D., Bush J. Psychological characteristics of young adolescents with inflammatory bowel disease. APA 117th Annual Convention; August 6-9, 2009; Toronto, Ontario, Canada 2009.
39. Tanaka M., Kazuma K. Ulcerative colitis: factors affecting difficulties of life and psychological well being of patients in remission. J Clin Nurs 2005, 14(1):65-73.
40. Vallis T., Leddin D. What makes Crohn's disease patients difficult to manage? The role of psychosocial factors. J Clin Psychol Med Settings Dec 2004, 11(4):325-332.
41. Voth J., Sirois F.M. The role of self-blame and responsibility in adjustment to inflammatory bowel disease. Rehabil Psychol Feb 2009, 54(1):99-108.
42. Kane S.V., Hanauer S.B. Medication adherence is associated with improved outcomes in patients with quiescent ulcerative colitis (UC). Gastroenterology 2000, 118(4, Part 1):A886.
43. Russel M.G., Nieman F.H., Bergers J.M., Stockbrugger R.W. Cigarette smoking and quality of life in patients with inflammatory bowel disease. South Limburg IBD Study Group. Eur J Gastroenterol Hepatol Nov 1996, 8(11):1075-1081. [Research Support, Non-U.S. Gov't].
44. Goodhand J.R., Wahed M., Rampton D.S. Management of stress in inflammatory bowel disease: a therapeutic option?. Expert Rev Gastroenterol Hepatol Dec 2009, 3(6):661-679. [Review].
45. Prasko J., Jelenova D., Mihal V. Psychological aspects and psychotherapy of inflammatory bowel diseases and irritable bowel syndrome in children. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub Dec 2010, 154(4):307-314.
46. Szigethy E., McLafferty L., Goyal A. Inflammatory bowel disease. Pediatr Clin North Am 2011, 58(4):903-920. [Date of Publication: August 2011.; 2011].
47. von Wietersheim J., Kessler H. Psychotherapy with chronic inflammatory bowel disease patients: a review. Inflamm Bowel Dis Dec 2006, 12(12):1175-1184. [Review].
48. Timmer A., Preiss J.C., Motschall E., Rucker G., Jantschek G., Moser G. Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database Syst Rev 2011, (5). [Systematic Review].
49. Barlow C., Cooke D., Mulligan K., Beck E., Newman S. A critical review of self-management and educational interventions in inflammatory bowel disease. Gastroenterol Nurs 2010, 33(1):11-18. [Review].
50. Colella E., Kim S., Squires M., Van Tilburg M. The feasibility of guided imagery treatment for abdominal discomfort in pediatric patients with quiescent inflammatory bowel disease: Inflammatory Bowel Diseases. Conference Publication: (var.pagings) 2011, 17:S42-S43. [Date of Publication: January 2011.; 2011].
51. Karwowski C., Srinath A., Newara M., Delaney P., Kirshner M., Ducharme P., et al. The effect of therapy on cost utilization in children with inflammatory bowel disease: Inflammatory Bowel Diseases. Conference Publication: (var.pagings) 2011, 17:S10. [Date of Publication: January 2011.; 2011].
52. Karwowski C., Srinath A.I., Newara M., Delaney P., Kirshner M.A., Ducharme P., et al. The effect of therapy on medical utilization in children with inflammatory bowel disease: Gastroenterology. Conference Publication: (var.pagings) 2011, 140 (5 Suppl. 1):S291. Date of Publication: May 2011.; 2011.
53. Reigada L., Masia Warner C., Benkov K., Waxman A., Briggie A., Dinkhaus C. Cognitive-behavioral treatment for youth with IBD and co-morbid anxiety disorders: results of an open pilot: Inflammatory Bowel Diseases. Conference Publication: (var.pagings) 2011, 17:S58. [Date of Publication: January 2011.; 2011].
54. Schwarz SP. Treatment of inflammatory bowel disease: comparing a multicomponent psychological treatment to a waiting-list control group. Dissertation Abstracts International [Dissertation] 1990 Jun;50(12-B, Pt 1):5919-20.
55. Keefer L., Kiebles J.L., Kwiatek M.A., Palsson O., Taft T.H., Martinovich Z., et al. The potential role of a self-management intervention for ulcerative colitis: a brief report from the Ulcerative Colitis Hypnotherapy Trial. Biological research for nursing February 28, 2011, [2011].
56. Schmidt C. Hypnotic suggestions and imaginations in the treatment of colitis ulcerosa. Hypnosis Dec 1992, 19(4):237-242.
57. Diaz Sibaja M.A., Comeche Moreno M.I., Mas Hesse B. Protocolized cognitive-behavioural group therapy for inflammatory bowel disease. Rev Esp Enferm Dig 2007 Oct, 99(10):593-598. [English Abstract. Randomized Controlled Trial. Validation Studies].
58. Shaw L., Ehrlich A. Relaxation training as a treatment for chronic pain caused by ulcerative colitis. Pain Jun 1987, 29(3):287-293.
59. Wahed M., Corser M., Goodhand J.R., Rampton D.S. Does psychological counseling alter the natural history of inflammatory bowel disease?. Inflamm Bowel Dis 2010, 16(4):664-669.
60. Garcia-Vega E., Fernandez-Rodriguez C. A stress management programme for Crohn's disease. Behav Res Ther Apr 2004, 42(4):367-383. [Randomized Controlled Trial].
61. Larsson K., Sundberg Hjelm M., Karlbom U., Nordin K., Anderberg U.M., Loof L. A group-based patient education programme for high-anxiety patients with Crohn disease or ulcerative colitis. Scand J Gastroenterol Jul 2003, 38(7):763-769. [Clinical Trial].
62. Smith G.D., Watson R., Roger D., McRorie E., Hurst N., Luman W., et al. Impact of a nurse-led counselling service on quality of life in patients with inflammatory bowel disease. J Adv Nurs 2002, 38(2):152-160.
63. Grootenhuis M.A., Maurice-Stam H., Derkx B.H., Last B.F. Evaluation of a psychoeducational intervention for adolescents with inflammatory bowel disease. Eur J Gastroenterol Hepatol Apr 2009, 21(4):340-345. [Research Support, Non-U.S. Gov't].
64. Szigethy E., Kenney E., Carpenter J., Hardy D.M., Fairclough D., Bousvaros A., et al. Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression. J Am Acad Child Adolesc Psychiatry Oct 2007, 46(10):1290-1298. [Randomized Controlled Trial. Research Support, N.I.H., Extramural. Research Support, Non-U.S. Gov't].
65. Langhorst J., Mueller T., Luedtke R., Franken U., Paul A., Michalsen A., et al. Effects of a comprehensive lifestyle modification program on quality-of-life in patients with ulcerative colitis: a twelve-month follow-up. Scand J Gastroenterol 2007, 42(6):734-745.
66. Jantschek G., Zeitz M., Pritsch M., Wirsching M., Klor H.U., Studt H.H., et al. Effect of psychotherapy on the course of Crohn's disease. Results of the German prospective multicenter psychotherapy treatment study on Crohn's disease. German Study Group on Psychosocial Intervention in Crohn's Disease. Scand J Gastroenterol Dec 1998, 33(12):1289-1296. [Clinical Trial. Multicenter Study. Randomized Controlled Trial. Research Support, Non-U.S. Gov't].
67. Oliveira S., Zaltman C., Elia C., Vargens R., Leal A., Barros R., et al. Quality-of-life measurement in patients with inflammatory bowel disease receiving social support. Inflamm Bowel Dis April 2007, 13(4):470-474.
68. Deter H.-C., Keller W., von Wietersheim J., Jantschek G., Duchmann R., Zeitz M. Psychological treatment may reduce the need for healthcare in patients with Crohn's disease. Inflamm Bowel Dis 2007, 13(6):745-752.
69. Kunsebeck H., Lempa W., Freyberger H. Short- and long-term effects of supplementary psychotherapy in patients with Crohn's disease 1987, Springer, Berlin. F. Lamprecht (Ed.).
70. Keefer L., Kiebles J., Matinovich Z., Cohen E., Van Denburg A., Barrett T. Behavioral interventions may prolong remission in patients with inflammatory bowel disease. Behav Res Ther 2011, 10.1016/j.brat.2010.12.005.
71. Boye B., Lundin K.E.A., Jantschek G., Leganger S., Mokleby K., Tangen T., et al. INSPIRE study: does stress management improve the course of inflammatory bowel disease and disease-specific quality of life in distressed patients with ulcerative colitis or Crohn's disease? A randomized controlled trial. Inflamm Bowel Dis Sep 2011, 17(9):1863-1873. [Randomized Controlled Trial].
72. Hommel K.A., Hente E.A., Odell S., Herzer M., Ingerski L.M., Guilfoyle S.M., et al. Evaluation of a group-based behavioral intervention to promote adherence in adolescents with inflammatory bowel disease. Eur J Gastroenterol Hepatol Jan 2012, 24(1):64-69. [Randomized Controlled Trial].
73. Hommel K.A., Herzer M., Ingerski L.M., Hente E., Denson L.A. Individually tailored treatment of medication nonadherence. J Pediatr Gastroenterol Nutr 2011, 53(4):435-439. [Date of Publication: October 2011.; 2011].
74. Vogelaar L., Van't Spijker A., Vogelaar T., Van Busschbach J.J., Visser M.S., Kuipers E.J., et al. Solution focused therapy: A promising new tool in the management of fatigue in Crohn's disease patients. Psychological interventions for the management of fatigue in Crohn's disease. J Crohns Colitis 2011, 5(6):585-591. [Date of Publication: December 2011.; 2011].
75. Keefer L., Doerfler B., Artz C. Optimizing management of Crohn's disease within a project management framework: results of a pilot study. Inflamm Bowel Dis 2012, 18(2):254-260.
76. Richardson G., Sculpher M., Kennedy A., Nelson E., Reeves D., Roberts C., et al. Is self-care a cost-effective use of resources? Evidence from a randomized trial in inflammatory bowel disease. J Health Serv Res Policy October 1 2006, 11(4):225-230. [2006].
77. Jayson D., Wood A., Kroll L.E.O., Fraser J., Harrington R. Which depressed patients respond to cognitive-behavioral treatment?. J Am Acad Child Adolesc Psychiatry 1998, 37(1):35-39.
78. Carter J.D., Luty S.E., McKenzie J.M., Mulder R.T., Frampton C.M., Joyce P.R. Patient predictors of response to cognitive behaviour therapy and interpersonal psychotherapy in a randomised clinical trial for depression. J Affect Disord 2011, 128(3):252-261.
79. Jarrett R.B., Eaves G.G., Grannemann B.D., Rush A.J. Clinical, cognitive, and demographic predictors of response to cognitive therapy for depression: a preliminary report. Psychiatry Res 1991, 37(3):245-260.
80. Neimeyer R.A., Weiss M.E. Cognitive and symptomatic predictors of outcome of group therapies for depression. J Cogn Psychother 1990, 4(1):23-32.
81. Simons A.D., Lustman P.J., Wetzel R.D., Murphy G.E. Predicting response to cognitive therapy of depression: the role of learned resourcefulness. Cogn Ther Res 1985, 9(1):79-89.
82. Thase M.E., Reynolds Iii C.F., Frank E., Simons A.D., McGeary J., Fasiczka A.L., et al. Do depressed men and women respond similarly to cognitive behavior therapy?. Am J Psychiatry 1994, 151(4):500-505.
83. Miehsler W., Weichselberger M., Öfferlbauer-Ernst A., Dejaco C., Reinisch W., Vogelsang H., et al. Which patients with IBD need psychological interventions? A controlled study. Inflamm Bowel Dis 2008, 14(9):1273-1280.
84. Ryan W.R., Allan R.N., Yamamoto T., Keighley M.R.B. Crohn's disease patients who quit smoking have a reduced risk of reoperation for recurrence. Am J Surg Feb 2004, 187(2):219-225. [Comparative Study].
85. Nigro G., Angelini G., Grosso S.B., Caula G., Sategna-Guidetti C. Psychiatric predictors of noncompliance in inflammatory bowel disease: psychiatry and compliance. J Clin Gastroenterol 2001, 32(1):66-68.
86. Mackner L.M., Crandall W.V. Oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis Nov 2005, 11(11):1006-1012. [Research Support, Non-U.S. Gov't].
87. Hunsley J. The cost-effectiveness of psychological interventions 2002, Canadian Psychological Association, Ottawa.
88. Minderhoud I.M., Oldenburg B., Wismeijer J.A., Van Berge Henegouwen G.P., Smout A.J.P.M. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci 2004, 49(3):469-474.
89. Morley S., Eccleston C., Williams A. Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy and behaviour therapy for chronic pain in adults, excluding headache. Pain Mar 1999, 80(1-2):1-13.
90. Malouff J.M., Thorsteinsson E.B., Rooke S.E., Bhullar N., Schutte N.S. Efficacy of cognitive behavioral therapy for chronic fatigue syndrome: a meta-analysis. Clin Psychol Rev Jun 2008, 28(5):736-745. [Meta-Analysis].
91. van der Feltz-Cornelis C.M., Nuyen J., Stoop C., Chan J., Jacobson A.M., Katon W., et al. Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis. Gen Hosp Psychiatry 2010, 32(4):380-395. [Meta-Analysis].
92. Ramaratnam S., Baker G.A., Goldstein L.H. Psychological treatments for epilepsy. Cochrane Database Syst Rev 2008, (3). [Article Number: CD002029. Date of Publication: 2008.; 2008].
93. MartinezDevesa P., Perera R., Theodoulou M., Waddell A. Cognitive behavioural therapy for tinnitus. Cochrane Database Syst Rev 2010, (9). [Systematic Review].
94. Hackett M.L., Anderson C.S., House A., Xia J. Interventions for treating depression after stroke. Cochrane Database Syst Rev 2009, (1). [Systematic Review].
95. Edwards A.G.K., Hulbert-Williams N., Neal R.D. Psychological interventions for women with metastatic breast cancer. Cochrane Database Syst Rev 2009, (1). [Systematic Review].
96. Zijdenbos I.L., de Wit N.J., van der Heijden G.J., Rubin G., Quartero A.O. Psychological treatments for the management of irritable bowel syndrome. Cochrane Database Syst Rev 2009, (1). [Systematic Review].
97. Kovacs Z., Kovacs F. Depressive and anxiety symptoms, dysfunctional attitudes and social aspects in irritable bowel syndrome and inflammatory bowel disease. Int J Psychiatry Med 2007, 37(3):245-255. [Comparative Study].
98. Mikocka-Walus A.A., Turnbull D.A., Moulding N.T., Wilson I.G., Andrews J.M., Holtmann G.J. Antidepressants and inflammatory bowel disease: a systematic review. Clin Pract Epidemiol Ment Health 2006, 2:24. [[Electronic Resource]: CP & EMH].
99. Mikocka-Walus A.A., Turnbull D.A., Moulding N.T., Wilson I.G., Andrews J.M., Holtmann G.J. "It doesn't do any harm, but patients feel better": a qualitative exploratory study on gastroenterologists' perspectives on the role of antidepressants in inflammatory bowel disease. BMC Gastroenterol 2007, 7:38.
100. Clarke D., Gibson P.R., Mikocka-Walus A. Can antidepressants influence the course of inflammatory bowel disease? The current state of research. Eur Gastroenterol Hepatol Rev 2009, 5:48-53.
101. Esmaeili A., Masjedi M., Ani A., Farajzadegan Z., Behbahani A., Dashti M., et al. 705 new insights of anti-depressant therapy in the management of ulcerative colitis (UC). Gastroenterology 2008, 134(4):A-100.
102. Goodhand J.R., Greig F.I.S., Koodun Y., McDermott A., Wahed M., Langmead L., et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case-matched observational study. Inflammatory Bowel Diseases. 2012 July, 18(7):1232-1239.
103. Viguera A.C., Baldessarini R.J., Friedberg J. Discontinuing antidepressant treatment in major depression. Harv Rev Psychiatry 1998, 5(6):293-306.
104. Paykel E.S., Scott J., Teasdale J.D., Johnson A.L., Garland A., Moore R., et al. Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Archives of General Psychiatry [Clinical Trial. Comparative Study. Randomized Controlled Trial. Research Support, Non-U.S. Gov't] 1999 Sep, 56(9):829-835.
105. Keller M.B., McCullough J.P., Klein D.N., Arnow B., Dunner D.L., Gelenberg A.J., et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000, 342(20):1462-1470.
106. Blackburn I.M., Bishop S., Glen A.I., Whalley L.J., Christie J.E. The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. Br J Psychiatry September 1 1981, 139(3):181-189. [1981].
107. McCrone P., Knapp M., Proudfoot J., Ryden C., Cavanagh K., Shapiro D.A., et al. Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial. Br J Psychiatry July 1 2004, 185(1):55-62. 2004.
108. Spence S., Donovan C., March S., Gamble A., Anderson R., Prosser S., et al. Randomized controlled trial of online versus clinic-based CBT for adolescent anxiety. J Consult Clin Psychol October. 2011, 79(5):629-642.
109. Kiropoulos L.A., Klein B., Austin D.W., Gilson K., Pier C., Mitchell J., et al. Is internet-based CBT for panic disorder and agoraphobia as effective as face-to-face CBT?. J Anxiety Disord 2008, 22(8):1273-1284.
110. Ljotsson B., Andersson G., Andersson E., Hedman E., Lindfors P., Andreewitch S., et al. Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial. BMC Gastroenterol 2011, 11:110. [Randomized Controlled Trial].
111. Ljotsson B., Falk L., Vesterlund A.W., Hedman E., Lindfors P., Ruck C., et al. Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome-a randomized controlled trial. Behav Res Ther Jun 2010, 48(6):531-539.
112. Ljotsson B., Hedman E., Andersson E., Hesser H., Lindfors P., Hursti T., et al. Internet-delivered exposure-based treatment vs. stress management for irritable bowel syndrome: a randomized trial. Am J Gastroenterol Aug 2011, 106(8):1481-1491. [Randomized Controlled Trial].
113. Ljotsson B., Hedman E., Lindfors P., Hursti T., Lindefors N., Andersson G., et al. Long-term follow-up of internet-delivered exposure and mindfulness based treatment for irritable bowel syndrome. Behav Res Ther Jan 2011, 49(1):58-61.
114. Buhrman M., Faltenhag S., Strom L., Andersson G. Controlled trial of Internet-based treatment with telephone support for chronic back pain. Pain Oct 2004, 111(3):368-377.
115. Buhrman M., Nilsson-Ihrfeldt E., Jannert M., Strom L., Andersson G. Guided internet-based cognitive behavioural treatment for chronic back pain reduces pain catastrophizing: a randomized controlled trial. J Rehabil Med May 2011, 43(6):500-505.
116. Chiauzzi E., Pujol L.A., Wood M., Bond K., Black R., Yiu E., et al. painACTION-Back Pain: a self-management website for people with chronic back pain. Pain Med Jul 2010, 11(7):1044-1058.
117. Berman R.L., Iris M.A., Bode R., Drengenberg C. The effectiveness of an online mind-body intervention for older adults with chronic pain. J Pain Jan 2009, 10(1):68-79.
118. Brattberg G. Internet-based rehabilitation for individuals with chronic pain and burnout: a randomized trial. Int J Rehabil Res Sep 2006, 29(3):221-227. [Randomized Controlled Trial].
119. Mikocka-Walus A., Andrews J.M. Cognitive-behavioural therapy (CBT) to manage inflammatory bowel disease (IBD): preliminary findings: Journal of Crohn's and Colitis. Conference Publication: (var.pagings) 2011, 5 (1):S142-S. [Date of Publication: February 2011.; 2011].
120. Mikocka-Walus A.A., Bond M., Holloway R.H., Persson J., Pilichiewicz A.N., Hughes P.A., et al. Does cognitive-behavioural therapy (CBT) improve outcomes in inflammatory bowel disease (IBD)? Initial feasibility report on a pilot randomised controlled trial: gastroenterology. Conference Publication: (var.pagings) 2010, 138 (5 Suppl. 1):S521-S522. [Date of Publication: May 2010.; 2010].